Trial Profile
A Randomized, Placebo-controlled Trial of Rosiglitazone for Treatment of Ulcerative Colitis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Oct 2023
Price :
$35
*
At a glance
- Drugs Rosiglitazone (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- Acronyms ROSIE
- 06 May 2011 Actual end date (Jan 2008) added as reported by ClinicalTrials.gov.
- 29 Jan 2010 New trial record